Amikacin Sulfate Patent Expiration

Amikacin Sulfate is used for treating Mycobacterium Avium Complex (MAC) lung disease in adults as part of a combination drug regimen. It was first introduced by Apothecon Inc Div Bristol Myers Squibb in its drug Amikin on Approved Prior to Jan 1, 1982. Other drugs containing Amikacin Sulfate are Amikin In Sodium Chloride 0.9% In Plastic Container, Arikayce Kit. 11 different companies have introduced drugs containing Amikacin Sulfate.


Amikacin Sulfate Patents

Given below is the list of patents protecting Amikacin Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Arikayce Kit US10251900 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US10751355 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US11446318 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US12016873 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US12168021 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US12168022 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US9895385 Methods for treating pulmonary non-tuberculous mycobacterial infections May 15, 2035 Insmed Inc
Arikayce Kit US9566234 Systems for treating pulmonary infections Jan 18, 2034 Insmed Inc
Arikayce Kit US8226975 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Aug 15, 2028 Insmed Inc
Arikayce Kit US8632804 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec 05, 2026 Insmed Inc
Arikayce Kit US8642075 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec 05, 2026 Insmed Inc
Arikayce Kit US8679532 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec 05, 2026 Insmed Inc
Arikayce Kit US7718189 Sustained release of antiinfectives Jun 06, 2025

(Expired)

Insmed Inc
Arikayce Kit US8802137 Sustained release of antiinfectives Apr 08, 2024

(Expired)

Insmed Inc
Arikayce Kit US9827317 Sustained release of antiinfectives Apr 08, 2024

(Expired)

Insmed Inc



Amikacin Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amikacin Sulfate Generic API Manufacturers

Several generic applications have been filed for Amikacin Sulfate. The first generic version for Amikacin Sulfate was by Apothecon Inc Div Bristol Myers Squibb and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Qilu Pharmaceutical Co Ltd and was approved on Mar 19, 2024.

Given below is the list of companies who have filed for Amikacin Sulfate generic, along with the locations of their manufacturing plants worldwide.